New lanostanoids from the fungus Ganoderma concinna.

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Cell Biology

Background:

• Ganoderma species are known sources of bioactive compounds.
• Triterpenoids and steroids are classes of compounds with diverse biological activities.
• Apoptosis induction is a key mechanism in cancer therapy.

Purpose of the Study:

• To isolate and characterize new compounds from Ganoderma concinna.
• To investigate the potential of these compounds to induce apoptosis in human promyelocytic leukemia HL-60 cells.

Main Methods:

• Isolation and purification of compounds using chromatographic techniques.
• Structure elucidation of new compounds utilizing Mass Spectrometry (MS) and Nuclear Magnetic Resonance (NMR) spectroscopy, including single-crystal X-ray diffraction for compound 3.
• Assessment of apoptosis induction through morphological examination and DNA fragmentation analysis via gel electrophoresis.

Main Results:

• Three new compounds (1-3) were isolated from Ganoderma concinna, alongside 12 known compounds.
• The structures of compounds 1 and 2 were determined by MS and NMR.
• The structure of compound 3 was confirmed by MS, NMR, and X-ray diffraction.
• Compounds 1, 2, and 3 were found to induce apoptosis in human promyelocytic leukemia HL-60 cells.

Conclusions:

• Ganoderma concinna is a source of novel bioactive compounds with cytotoxic potential.
• Compounds 1, 2, and 3 exhibit apoptosis-inducing activity against HL-60 leukemia cells.
• These findings suggest potential therapeutic applications for these natural products in leukemia treatment.